BMI in the lower and upper quartiles at diagnosis and at 1-year follow-up is significantly associated with higher risk of disease exacerbation in pediatric inflammatory bowel disease

2020 ◽  
Vol 180 (1) ◽  
pp. 21-29
Author(s):  
Anat Yerushalmy-Feler ◽  
Tut Galai ◽  
Hadar Moran-Lev ◽  
Amir Ben-Tov ◽  
Margalit Dali-Levy ◽  
...  
2021 ◽  
Vol 15 (Supplement_1) ◽  
pp. S275-S276
Author(s):  
A Yerushalmy-Feler ◽  
S Cohen

Abstract Background Previous studies have shown a lower level of parasympathetic activity in patients with inflammatory bowel disease (IBD) compared to healthy subjects. Heart rate variability (HRV) oscillations are used to detect autonomic instability and was found to be lower in adults with IBD compared to controls. Nevertheless, the data on the relation between the autonomic function and IBD outcome are scarce. The aim of the study was to evaluate HRV as a predictor to paediatric IBD outcome. Methods Children (<18 years of age) with IBD were prospectively recruited. For each patient, a 10-minute measurement of HRV was conducted by Pulse Oximeter (BM1000A/Shanghai Berry Electronic Tech Co., Ltd). The square root of the mean squared differences of successive RR intervals (RMSSD) was calculated. Clinical data, including demographic variables, disease activity and course, medications and laboratory results were collected during a follow-up of 12 months. The relation between RMSSD and clinical measures was evaluated. Results Overall, 34 IBD children with an average age of 15.32±2.18 years were included: 21 (61.8%) children with Crohn’s disease and 13 (38.2%) with ulcerative colitis. Children in clinical remission had a significantly higher RMSSD compared to patients with active disease (67.72±27.81 and 45.76±22.04, respectively, p=0.022). In addition, patients with normal serum C-reactive protein (<5 mg/L), patients with normal serum hemoglobin and patients with long duration of IBD (more than a year from diagnosis) had a significantly higher RMSSD (Figure 1). Children that experienced disease exacerbation during the follow-up had a significantly lower RMSSD compared to children that kept clinical remission (Figure 2). In a multivariate analysis, higher RMSSD was a significant and independent predictor of lower risk of IBD exacerbation [OR (odd ratio) = 0.941, 95% CI (confidence interval) 0.887–0.998, p=0.044)]. Conclusion HRV may not only reflect IBD activity, but also serve as a predictor to disease exacerbation in paediatric IBD.


2016 ◽  
Vol 5 (1) ◽  
pp. u208961.w3675 ◽  
Author(s):  
Dana Dykes ◽  
Elizabeth Williams ◽  
Peter Margolis ◽  
Jennifer Ruschman ◽  
Julianne Bick ◽  
...  

Digestion ◽  
2004 ◽  
Vol 70 (4) ◽  
pp. 226-230 ◽  
Author(s):  
Ketil Størdal ◽  
Jørgen Jahnsen ◽  
Beint S. Bentsen ◽  
Bjørn Moum

2020 ◽  
Vol 7 (1) ◽  
pp. e000373
Author(s):  
Tarik Alhmoud ◽  
Anas Gremida ◽  
Diego Colom Steele ◽  
Imaneh Fallahi ◽  
Wael Tuqan ◽  
...  

BackgroundInflammatory bowel disease (IBD) is characterised by acute intestinal mucosal inflammation with chronic inflammatory features. Various degrees of mucosal eosinophilia are present along with the typical acute (neutrophil-predominant) inflammation. The effect of intestinal eosinophils on IBD outcomes remains unclear.MethodsThis is a retrospective study. Archived intestinal mucosal biopsy specimens of treatment-naïve IBD patients were examined by two pathologists. The number of eosinophils per high-power field was counted, and the mucosal inflammation was classified according to the eosinophilic inflammatory patterns. Clinical outcomes during the follow-up period were recorded.Results142 treatment-naïve IBD patients were included. Mean age was 39 years. 83% of patients had ulcerative colitis, and median follow-up was 3 years. 41% of patients had disease flare(s) and 24% required hospitalisation. Eosinophil count was not associated with risk of disease flare or hospitalisation. Patients with neutrophil-predominant inflammation (>70% neutrophils) had greater risk of disease flare(s): 27(55%) versus 24(36%) and 7(28%) in patients with mixed and eosinophil-predominant inflammation, respectively (p=0.04). Overall, patients with neutrophil-predominant inflammation were more likely to have a disease flare; HR: 2.49, 95% CI (1.0 to 5.6). Hospitalisation rate was higher in patients with neutrophil-predominant inflammation: 17(35%) compared to 17(19%) in patients with eosinophil-rich inflammation (p=0.04). Kaplan–Meier analysis showed higher flare-free survival in patients with eosinophil-predominant inflammation compared to mixed and neutrophil-predominant inflammation.ConclusionIBD patients with eosinophil-predominant inflammation phenotype might have reduced risk of disease flares and hospitalisation. Larger prospective studies to assess IBD outcomes in this subpopulation are warranted.


2019 ◽  
Author(s):  
Janice S. Cohen ◽  
John S. Lyons ◽  
Eric I. Benchimol ◽  
Nicholas Carman ◽  
Camille Guertin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document